Benzinga's Top #PreMarket Losers
March 11, 2014 at 08:18 AM EDT
Myriad Genetics (NASDAQ: MYGN) shares dropped 9.27% to $34.25 in pre-market trading after the US Court denied the company's motion to ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.